That doesn't imply they are not thinking about it. Many breakthrough therapy designations have already been granted for psilocybin during the treatment of resistant depression—that may be, depression that does not reply to at least two differing kinds of antidepressants—and a broader acceptance can be around the horizon.In rodents, psilocybin h